Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health And Safety topic
No spam. Unsubscribe anytime.
Panel outlines health‑and‑safety regulatory steps: provisional hiring, background‑check streamlining and stock epinephrine plan
Summary
Committee received updates on regulatory work to align general procedures and background checks with the Code of Virginia, a new provisional hiring law that allows supervised staff to start while checks are pending, and a forthcoming requirement for licensed centers to hold standing‑order stock epinephrine with associated training and rollout timelines.
The advisory committee heard several health‑and‑safety updates from Department of Education staff and partners, including a fast‑track regulatory alignment, a provisional hiring law that eases staffing bottlenecks, and planning for center‑level access to stock epinephrine.
Background checks and general procedures: staff said they consolidated and streamlined general procedures and background‑check regulations to reduce duplication with the Code of Virginia; the rewritten regulations were published in the register of regulations and will accept public comment. Department staff and legal counsel are preparing webinars and guidance to explain changes to local licensing offices and providers.
Provisional hiring: a new law passed this session allows provisional hiring so that an applicant who has a pending state or FBI background check may begin supervised work (shadowing and training) under direct supervision rather than waiting multiple weeks for clearance. Staff said the change followed several years of stakeholder advocacy to reduce hiring delays that could take four to six weeks.
Stock epinephrine and standing orders: the committee discussed a statutory and regulatory path for licensed centers to hold stock epinephrine for emergency use. Staff said the Department of Health and the Board of Pharmacy must authorize standing orders and that the department is developing a streamlined training option so centers that choose to administer epinephrine will not be required to complete the full MAT training now used for some providers. Cost estimates for doses varied widely in committee discussion; staff noted a vendor search found some doses priced at $3.25–$6.25 and other market quotes in the hundreds, and they said donation, contract purchasing or state procurement could reduce per‑site cost. Staff said it is unlikely that monitoring or enforcement of the new epi requirement will begin before spring of next year because DOE must finalize regulations, secure standing orders, develop training and give providers time to adopt new protocols.
Next steps: DOE will publish explanatory materials and webinar dates and work with the Department of Health to finalize the standing‑order model and the inspector guidance. Committee members asked for implementation timelines, likely costs and whether DOE can help reduce per‑site procurement costs through contracts or subsidy support.
